Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The 90s paradox: QA efforts reduce total quality.

M J Fuller1, P V Holland

  • 1Sacramento Medical Foundation Blood Centers, CA 95816-7089, USA.

Transfusion Science
|November 3, 1997
PubMed
Summary

Focusing solely on infectious risk reduction in blood transfusions strains resources. This approach, while enhancing safety, may compromise overall blood product quality and potency, necessitating a balanced quality assurance strategy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.

Vox sanguinis·2010
Same author

Periodic magnetic field as a polarized and focusing thermal neutron spectrometer and monochromator.

The Review of scientific instruments·2010
Same author

Does donating blood for the first time during a national emergency create a better commitment to donating again?

Vox sanguinis·2009
Same author

TRALI is due to pulmonary venule damage from leucocytes with cholesterol crystal formation.

Vox sanguinis·2009
Same author

Transfusion-associated graft-versus-host disease.

Vox sanguinis·2008
Same author

Selling blood vs. donating blood.

Vox sanguinis·2008

Area of Science:

  • Transfusion Medicine
  • Healthcare Resource Allocation
  • Quality Assurance in Healthcare

Background:

  • The

Purpose of the Study:

  • To analyze the impact of prioritizing infectious risk reduction on overall blood product quality.
  • To evaluate the cost-effectiveness of current blood safety measures.
  • To advocate for a more balanced approach to quality assurance in blood banking.

Main Methods:

  • Review of resource allocation in blood centers.
  • Analysis of investments in blood safety testing versus other quality enhancements.
  • Examination of customer expectations and willingness to pay for blood product attributes.

Main Results:

  • Significant resources are allocated to marginal safety improvements, potentially depleting funds for other quality aspects like potency.
  • Current quality assurance (QA) investments may not yield proportional benefits, impacting overall quality.
  • Customers desire enhanced safety but are reluctant to fund it, while overlooking potency and efficacy.

Conclusions:

  • A sole focus on "closing the window" of infectious risks in transfusion medicine may be resource-inefficient.
  • Blood service providers must demonstrate the value of QA activities to ensure reimbursement.
  • Achieving total quality in blood banking requires balancing safety with other critical attributes like potency and efficacy.

Related Experiment Videos